SLC5A2 and atrial fibrillation: Assuming that catheter ablation will improve the clinical outcome and lower the AF recurrence rate compared to that achieved with the AAD-only treatment in patients with AF and DM, we will add the following procedures after the random assignment of SGLT-2 inhibitors to minimize the bias caused by study protocols: First, the patient takes the assigned medicine for at least 3 months.